<unk>  can be used to treat bacteria responsible for causing infections of the skin and upper respiratory tract, including Streptococcus, Staphylococcus, Haemophilus and Corynebacterium genera. The following represents MIC susceptibility data for a few medically significant bacteria: * Haemophilus influenzae: 0.015 to 256 μg/ml * Staphylococcus aureus: 0.023 to 1024 μg/ml * Streptococcus pyogenes: 0.004 to 256 μg/ml * Corynebacterium minutissimum: 0.015 to 64 μg/ml It may be useful in treating gastroparesis due to this promotility<unk> ffect. It has been shown to improve feeding intolerances in those who are critically ill. Intravenous<unk>  may also be used in<unk> ndoscopy to help clear stomach contents. Available forms<unk> nteric-coated<unk>  capsule from Abbott Labs<unk>  is available in<unk> nteric-coated tablets, slow-release capsules, oral suspensions, ophthalmic solutions, ointments, gels,<unk> nteric-coated capsules, non<unk> nteric-coated tablets, non<unk> nteric-coated capsules, and injections. The following<unk>  combinations are available for oral dosage:<unk>  base (capsules, tablets)<unk> <unk> stolate (capsules, oral suspension, tablets), contraindicated during pregnancy<unk> <unk> thylsuccinate (oral suspension, tablets)<unk>  stearate (oral suspension, tablets) For injection, the available combinations are:<unk>  gluceptate<unk>  lactobionate For ophthalmic use:<unk>  base (ointment)
Erythromycin
Cethromycin
Methicillin
Ampicillin
Meropenem
Clarithromycin
Natamycin
Cefotaxime